Ionis Pharmaceuticals (IONS) Receivables (2009 - 2017)
Ionis Pharmaceuticals (IONS) posted quarterly Receivables of $125.9 million for Q4 2017, up 16.54% year-over-year from $108.0 million in Q4 2016, and up 193.33% quarter-over-quarter from $42.9 million in Q3 2017.
Ionis Pharmaceuticals (IONS) Receivables (2009 - 2017) Analysis & Trends
Ionis Pharmaceuticals' Receivables history runs 9 years deep, the most recent figure standing at $125.9 million for Q4 2017.
- In Q4 2017, Receivables rose 16.54% year-over-year to $125.9 million; the TTM figure through Dec 2017 stood at $125.9 million (up 16.54% YoY), while the FY2017 annual figure was $125.9 million, up 16.54% from the prior year.
- Receivables for Q4 2017 stood at $125.9 million, up from $42.9 million in the prior quarter.
- The five-year high for Receivables was $125.9 million in Q4 2017, with the low at $746000.0 in Q2 2016.
- The 5-year median for Receivables is $12.0 million (2013), against an average of $28.7 million.
- The sharpest annual moves came in 2015 and 2017: Receivables slumped 93.06% in 2015, then surged 6684.85% in 2017.
- Ionis Pharmaceuticals' Receivables stood at $11.1 million in 2013, then plunged by 64.84% to $3.9 million in 2014, then surged by 190.96% to $11.4 million in 2015, then surged by 851.42% to $108.0 million in 2016, then grew by 16.54% to $125.9 million in 2017.
- Business Quant data shows IONS's Receivables at $125.9 million in Q4 2017, $42.9 million in Q3 2017, and $50.6 million in Q2 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.93 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.06 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 1.84 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 912.74 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 215.33 Mn |
| 10 | Ionis Pharmaceuticals | 9.48 Bn | 7.43 Bn | 265.21 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 125.91 Mn |
| Sep 30, 2017 | 42.92 Mn |
| Jun 30, 2017 | 50.62 Mn |
| Mar 31, 2017 | 69.36 Mn |
| Dec 31, 2016 | 108.04 Mn |
| Sep 30, 2016 | 8.54 Mn |
| Jun 30, 2016 | 746,000.00 |
| Mar 31, 2016 | 16.48 Mn |
| Dec 31, 2015 | 11.36 Mn |
| Sep 30, 2015 | 1.83 Mn |
| Jun 30, 2015 | 3.26 Mn |
| Mar 31, 2015 | 26.93 Mn |
| Dec 31, 2014 | 3.90 Mn |
| Sep 30, 2014 | 26.31 Mn |
| Jun 30, 2014 | 41.94 Mn |
| Mar 31, 2014 | 9.82 Mn |
| Dec 31, 2013 | 11.10 Mn |
| Sep 30, 2013 | 12.65 Mn |
| Jun 30, 2013 | 2.02 Mn |
| Mar 31, 2013 | 1.17 Mn |